SanBio Co Ltd

NEW
OTCPK:SNBIF (Japan)  
$ 16.45 (0%) 08:08 PM EST
At Loss
P/B:
6.61
Market Cap:
$ 480.94M
Enterprise V:
$ 379.19M
Volume:
0
Avg Vol (2M):
0
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
0

Business Description

Description
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
Name Current Vs Industry Vs History
Cash-To-Debt
11.64
Equity-to-Asset
0.87
Debt-to-Equity
0.1
Debt-to-EBITDA
-0.37
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
14-Day RSI
100
12-1 Month Momentum %
151.15

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
53
Quick Ratio
53
Cash Ratio
51.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-6.8
Shareholder Yield %
-20.43

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-52.52
ROA %
-39.37
ROIC %
-749.15
3-Year ROIIC %
-1336.55
ROC (Joel Greenblatt) %
-1948.81
ROCE %
-43.56

Financials

SNBIF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:SNBIF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

SanBio Co Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.271
Beta -0.3261
3-Year Sharpe Ratio 0.67
3-Year Sortino Ratio 3.48
Volatility % 117.61
14-Day RSI 100
14-Day ATR ($) 0.000007
20-Day SMA ($) 16.45
12-1 Month Momentum % 151.15
52-Week Range ($) 6.55 - 16.45
Shares Outstanding (Mil) 78.04

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

SanBio Co Ltd Filings

Filing Date Document Date Form
No Filing Data

SanBio Co Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

SanBio Co Ltd Frequently Asked Questions

What is SanBio Co Ltd(SNBIF)'s stock price today?
The current price of SNBIF is $16.45. The 52 week high of SNBIF is $16.45 and 52 week low is $6.55.
When is next earnings date of SanBio Co Ltd(SNBIF)?
The next earnings date of SanBio Co Ltd(SNBIF) is .
Does SanBio Co Ltd(SNBIF) pay dividends? If so, how much?
SanBio Co Ltd(SNBIF) does not pay dividend.

Guru Commentaries on OTCPK:SNBIF

No articles.

Press Release

Subject Date
No Press Release

Articles on SanBio Co Ltd

No articles.

Headlines

See More
  • 1
No news.
  • 1